Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases

Accessibility Controls

Implementing Organization

Indian Institute of Chemical Technology (IICT)

Project Overview

Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.

Benefits

The process involves
: Preparation of Myristoleic acid from oleic/undecenoic acid
, Transesterification of Myristoleic acid with cetyl alcohol to obtain cetyl myristoleate isomers

Source

Source URL

www.iictindia.org

Related Research

View All

Quick Information

Thrust Areas

Medical Sciences

Focus Area

Treatment of Osteoarthritis

Output

TRL: Technology Readiness Level

Lab Validation

Accessibility Controls

All Technologies